✦ LIBER ✦

Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension

✍ Scribed by George Carruthers; Pierre Dessain; George Fodor; Christopher Newman; Wilfred Palmer; Dalice Sim

Book ID: 113118905
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 891 KB
Volume: 71
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(93)90514-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of doxazosin and atenolol on endo

Effect of doxazosin and atenolol on endothelial function in essential hypertension

✍ Giuseppe Schillaci; Simona Marchesi; Gaetano Vaudo; Graziana Lupattelli; Fabio G 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Effects of doxazosin and atenolol on the

Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol

✍ J. -H. Jansson; B. Johansson; K. Boman; T. K. Nilsson 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 740 KB

Disturbances in the fibrinolytic system have been associated with cardiovascular disease and its risk factors. In the present study the effects of an alpha 1-adrenoceptor inhibitor (doxazosin) and a selective beta-adrenoceptor blocker (atenolol) on the fibrinolytic system have been evaluated. Eighty

A double-blind parallel trial to assess

A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension

✍ David T. Nash; Gustav Schonfeld; Robert L. Reeves; Henry Black; Donald J. Weidle 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Past, present, and future clinical trial

Past, present, and future clinical trials of cardiovascular risk reduction—the hypertension perspective

✍ Toshiro Fujita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beever 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 124 KB

Regression of hypertensive left ventricu

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

✍ R.B. Devereux; B. Dahlof; E. Gerdts 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB